VERA Vera Therapeutics Inc
Company Analysis
Latest News
🟢 Vera Therapeutics is trading 6.66% up in pre-market — no clear company-specific catalyst
Vera Therapeutics is trading at $33.00, up 6.66% in pre-market, with no clear, new company-specific catalyst identified for October 29. - Shares had also...
🟢 Vera Therapeutics is trading 6.7% up in pre-market — catalyst remains unclear
Vera Therapeutics is trading 6.7% up at $32.00, with no clear immediate catalyst identified. - It closed at $29.99 on October 27; the prior session rose 5.97%...
🔴 Vera Therapeutics is trading 8.3% down in pre-market with no fresh company announcement identified
Vera Therapeutics is trading 8.3% down in pre-market at $27.50; no fresh company announcement explaining the decline was identified. - On October 27, shares...
🟢 Vera Therapeutics is trading 4.24% up; catalyst remains unclear
Vera Therapeutics is trading 4.24% up at $29.50, with no clear catalyst identified for the move. - Positive ORIGIN 3 final efficacy results were announced on...
🔴 Vera Therapeutics is trading 4.6% down in pre-market with no clear company-specific catalyst identified
Vera Therapeutics is trading at $27.00, down 4.59%, with no clear company-specific announcement identified to explain the October 27 pre-market decline. -...
🟢 Vera Therapeutics is trading 5% up in pre-market
Vera Therapeutics is trading at $29.78, up 5.23% in pre-market, with no clear company-specific announcement identified for October 27, 2026. - The company’s...
🔴 Vera Therapeutics is trading 4.13% down amid biotech sector pressure
Vera Therapeutics is trading at $27.85, down 4.13%, amid biotech-sector pressure; no clear new company-specific negative announcement explains the October 23...
🔴 Vera Therapeutics is trading 4.3% down today amid AI-spending concerns and rising oil prices
Vera Therapeutics is trading 4.3% down at $29.85; no company-specific news clearly explains the decline amid AI-spending concerns and rising oil prices amid...
🟢 Vera Therapeutics is trading at 4.3% up today as investors eye ORIGIN 3 results webcast
Vera Therapeutics is trading 4.3% higher at $31.35, with investors potentially positioning ahead of the October 22 webcast on final ORIGIN 3 results. - Results...
🟢 Vera Therapeutics is trading 4.46% up amid biotech ETF XBI's reported 2.10% gain
Vera Therapeutics is trading at $30.21 (+4.46%) amid stronger biotech-sector sentiment, with XBI reported up 2.10%. - No clear company-specific announcement...
🟢 Vera Therapeutics rises 4.3% — Biotech Sector Rallies on M&A Activity and Anticipation of Key Cancer Data
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector moved higher, fueled by news that...
🟢 Vera Therapeutics is trading 5% up today as biotech sector gains 2.20%
Vera Therapeutics is trading at $28.14, up 5.24%, with the move consistent with biotech-sector strength. - The biotech sector is up 2.20%. - No new...
🔴 Vera Therapeutics is trading 4.02% down with no clear catalyst identified
Vera Therapeutics is trading 4.02% down at $28.68 on October 12, 2026; the specific driver remains unclear. - The S&P 500 was down 0.06% and the Nasdaq...
🔴 Vera Therapeutics is trading 4.03% down today amid biotech-sector weakness
Vera Therapeutics is trading at $29.03, down 4.03%, amid biotech-sector weakness; no clear company-specific announcement explains the decline. - Recent...
🟢 Vera Therapeutics is trading 4% up with no clear company-specific catalyst
Vera Therapeutics is trading at $30.60, up 4.01%, with no clear company-specific catalyst emerging for its October 7, 2026 gain. - Company announcements found...
🔴 Vera Therapeutics is trading 4.3% down today amid biotech weakness
Vera Therapeutics is trading 4.3% down at $28.55 now, with biotech weakness a possible backdrop; no definitive catalyst has been established. - The broader...
🔴 Vera Therapeutics is trading 4.5% down
Vera Therapeutics is trading 4.5% lower at $29.07, with no clear company-specific announcement or report identified to explain the October 5 decline. - The...
Vera Therapeutics to Present Final ORIGIN 3 Results at ASN Kidney Week
Vera Therapeutics will present the final efficacy analysis from its pivotal ORIGIN 3 trial of TRUTAKNA for IgA nephropathy (IgAN) in a late-breaking oral...
🔴 Vera Therapeutics is trading 4.12% down with no clear catalyst identified
Vera Therapeutics is trading 4.12% down at $30.96, and the specific reason for the decline remains unclear. - Available coverage reports no new...
🔴 Vera Therapeutics is trading 7.81% down in pre-market amid broader risk-off conditions
Vera Therapeutics is trading at $30.00, down 7.81% in pre-market on September 28, 2026, versus the September 25 close of $32.54, amid broader risk-off...